Congress Asset Management Co. Reduces Holdings in LeMaitre Vascular, (NASDAQ:LMAT)
April 2, 2023
Trending News ☀️
LEMAITRE ($NASDAQ:LMAT): Congress Asset Management Co. recently made a substantial reduction in their holdings of LeMaitre Vascular, Inc. (NASDAQ:LMAT). LeMaitre Vascular is a medical device company that develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. Its products include the LeMaitre Vascular Grafts, Valvulotomes, Probes, and other products. The company’s products are used to treat peripheral vascular disease, aortic aneurysms, carotid artery disease, and other conditions.
The company has had a long-standing relationship with Congress Asset Management Co., who has reduced their holdings in LeMaitre Vascular for unknown reasons. While the reason for the reduction is unknown, it could be indicative of the company’s current performance. It remains to be seen how the company’s stock will perform in the future.
Share Price
The stock opened at $51.9 and closed at $51.7, a slight 0.2% increase from the previous closing price of $51.6. The news of Congress Asset Management Co.’s decreased holdings sent some investors into a slight panic, though the stock responded positively overall. The company specializes in the development, manufacture and marketing of diagnostic and therapeutic devices used in vascular surgery. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Lemaitre Vascular. More…
| Total Revenues | Net Income | Net Margin |
| 161.65 | 20.64 | 14.2% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Lemaitre Vascular. More…
| Operations | Investing | Financing |
| 25.38 | -10.37 | -9.23 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Lemaitre Vascular. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 310.48 | 42.27 | 12.14 |
Key Ratios Snapshot
Some of the financial key ratios for Lemaitre Vascular are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 11.3% | 12.2% | 17.0% |
| FCF Margin | ROE | ROA |
| 13.7% | 6.5% | 5.5% |
Analysis
At GoodWhale, we conducted an analysis of LEMAITRE VASCULAR‘s financials, and found that it is strong in asset, dividend, growth, and profitability. We classified the company as ‘rhino’, a type of company that has achieved moderate revenue or earnings growth. This type of company may be of interest to investors looking for a stable company that has the potential for slow, steady growth. We also found that LEMAITRE VASCULAR has a very high health score of 10/10. This is due to its strong cashflows and low debt. This indicates that the company is well-positioned to sustain its operations in times of crisis. More…
Peers
It focuses on the development, manufacture and marketing of minimally invasive products for the treatment of peripheral vascular diseases. The company operates through two segments, Direct and OEM. The Direct segment offers proprietary products to hospitals and other medical institutions through direct sales force. The OEM segment provides stents and other products to Original Equipment Manufacturers (OEMs) for sale under their own brands. LeMaitre’s competitors include Atrion Corp, Implanet SA, Vycor Medical Inc.
– Atrion Corp ($NASDAQ:ATRI)
Atrion Corporation is a medical device company that develops, manufactures and markets products primarily for use in cardiac and ophthalmic surgery. The company’s products include Cardiax, a cannula used in cardiac surgery; Ophthalmic products, including the HydroVue and Glaucoma Shunt systems to treat glaucoma; and PerQCat, a catheter used in urology procedures.
– Implanet SA ($OTCPK:IMPZY)
Implanet SA is a French company specializing in the design and manufacture of medical implants for the treatment of orthopedic pathologies. The company’s products are used in the treatment of various conditions, including osteoarthritis, degenerative disc disease, scoliosis, and deformities of the hip, knee, and shoulder. As of 2022, Implanet SA had a market capitalization of 3.88 million euros and a return on equity of -114.56%. The company’s products are sold in over 50 countries worldwide and its customers include some of the world’s leading orthopedic surgeons and hospitals.
– Vycor Medical Inc ($OTCPK:VYCO)
Vycor Medical Inc is a medical device company that specializes in the development and commercialization of minimally invasive products for neurosurgery. The company’s products are designed to provide surgeons with improved access and visualization during surgery, while minimizing tissue damage and surgical time. Vycor Medical’s products are sold in over 30 countries worldwide.
As of 2022, Vycor Medical Inc had a market capitalization of 3.17 million and a return on equity of 6.36%. The company’s products are used in a variety of neurosurgical procedures, including brain surgery, spinal surgery, and skull-base surgery.
Summary
Congress Asset Management Co. MA recently trimmed its stocks in LeMaitre Vascular, Inc. (NASDAQ:LMAT), a medical device company focusing primarily on the manufacturing and marketing of peripheral vascular devices. This move speaks to the company’s outlook on the stock’s performance; Congress Asset Management Co. MA is reducing their exposure to the company. Investors should keep an eye on the stock to determine the reasons for this move and evaluate the impact it could have on their own portfolios.
The medical device sector has been quite volatile in recent years, with many companies in the space experiencing highs and lows. Thus, investors should pay attention to any further changes in Congress Asset Management Co. MA’s holdings and how it might affect their own investing plans.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
